Kiowski W, Hulthén U L, Ritz R, Bühler F R
Clin Pharmacol Ther. 1983 Nov;34(5):565-9. doi: 10.1038/clpt.1983.216.
We investigated the possibility that adrenoceptors of the alpha 2 subtype mediate vasoconstriction of arteries in response to administered catecholamines. Clonidine, which in vitro, stimulates alpha 2-adrenoceptors was infused into a brachial artery in 12 subjects (0.48 micrograms/min/100 ml tissue for 3 min). Afterward, prazosin was infused intraarterially in the first six subjects (0.5 micrograms/min/100 ml for 10 min) and in the remaining subjects, phentolamine was infused (0.12 micrograms/min/100 ml) for 10 min. Subsequently, the clonidine infusion was repeated. Clonidine decreased forearm blood flow from 3.5 +/- 0.52 to 1.8 +/- 0.32 in the first six subjects and from 4.2 +/- 0.84 to 2.7 +/- 0.61 ml/min/100 ml in the other subjects. Alpha 1-Adrenoceptor blockade by prazosin increased forearm blood flow by 122.7 +/- 33.8% and combined alpha 1 and alpha 2 blockade by phentolamine by 127.2 +/- 29.9%, indicating much the same degree of postjunctional alpha-adrenoceptor blockade. Alpha 2-Adrenoceptor-mediated vasoconstriction by clonidine was abolished after phentolamine (9.1 +/- 2.29 and 9 +/- 2.51 ml/min/100 ml) but was still present after prazosin (7.8 +/- 1.7 and 4.8 +/- 1.6 ml/min/100 ml). The results suggest that, apart from the classical alpha 1 adrenoceptor, there is a second type of adrenergic receptor on smooth muscle cells that can mediate vasoconstriction, resembling the alpha 2-adrenoceptor pharmacologically.
我们研究了α2亚型肾上腺素能受体介导动脉血管收缩以响应给予的儿茶酚胺的可能性。将在体外刺激α2 - 肾上腺素能受体的可乐定注入12名受试者的肱动脉(0.48微克/分钟/100毫升组织,共3分钟)。之后,在前6名受试者中动脉内注入哌唑嗪(0.5微克/分钟/100毫升,共10分钟),其余受试者注入酚妥拉明(0.12微克/分钟/100毫升),持续10分钟。随后,重复可乐定输注。在前6名受试者中,可乐定使前臂血流量从3.5±0.52降至1.8±0.32,在其他受试者中从4.2±0.84降至2.7±0.61毫升/分钟/100毫升。哌唑嗪对α1 - 肾上腺素能受体的阻断使前臂血流量增加了122.7±33.8%,酚妥拉明对α1和α2的联合阻断使前臂血流量增加了127.2±29.9%,表明节后α - 肾上腺素能受体阻断程度大致相同。酚妥拉明注射后,可乐定介导的α2 - 肾上腺素能受体血管收缩作用消失(9.1±2.29和9±2.51毫升/分钟/100毫升),但哌唑嗪注射后仍存在(7.8±1.7和4.8±1.6毫升/分钟/100毫升)。结果表明,除了经典的α1肾上腺素能受体外,平滑肌细胞上还存在第二种能介导血管收缩的肾上腺素能受体,其药理学特性类似于α2 - 肾上腺素能受体。